ArticleFrontiers in immunology2025

Enhancing anti-tumor immunity through co-blocking PD-L1 and TIGIT by facilitating tumor-directed responses and additional VEGF inhibition.

Xi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.